Enhancing Renal Masses With Zero Net Growth During Active Surveillance
Author:
Affiliation:
1. Department of Urologic Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, Pennsylvania
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference20 articles.
1. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature;Chawla;J Urol,2006
2. Increased incidence of serendipitously discovered renal cell carcinoma;Jayson;Urology,1998
3. The natural history of incidentally detected small renal masses;Volpe;Cancer,2004
4. Management of renal masses in patients medically unsuitable for nephrectomy—natural history, complications, and outcome;Lamb;Urology,2004
5. Independent validation of the 2002 American Joint Committee on Cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort;Frank;J Urol,2005
Cited by 188 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tracing the evolving dynamics and research hotspots in the kidney neoplasm and nephron sparing surgery field from the past to the new era;Cancer Medicine;2024-06
2. Scientific Status Quo of Small Renal Lesions: Diagnostic Assessment and Radiomics;Journal of Clinical Medicine;2024-01-18
3. Diagnosis and Treatment of Small Renal Masses: Where Do We Stand?;Current Urology Reports;2022-05-04
4. Overview of clinical management for older patients with renal cell carcinoma;Japanese Journal of Clinical Oncology;2022-04-10
5. The impact of tumor size on the survival of patients with small renal masses: A population–based study;Cancer Medicine;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3